Business & Investment

Stock Market Live Today | Sensex, Nifty, BSE, NSE, Stock, Stock Market News Update January 4th

Indian drug regulators have approved the Oxford Covid-19 Vaccine Covishield, which was manufactured by the Serum Institute of India (SII) and independently developed Barrat Biotech’s Covacin.

Today’s Stock Market News | Sensex, Nifty, Stock Live: After a good start to the new year, the domestic stock market is looking for more of the same as entering the first full week of 2021. S & P BSE Sensex Currently, 50 shares of NSE Nifty are 14,018, compared to 47,868, the highest closing price ever. SGX Nifty traded at a high of over 75 points on Monday morning, suggesting a start to the gap in the domestic stock market. However, Asian stock indexes were trading in different ways. The Shanghai Composite Index was trading flat with a positive bias, but the Hang Seng Index rose almost half a percent. The Korean stock market was also green with KOSPI jumping 1.161%, but TOPIX and Nikkei 225 were trading in red.

India granted approval for two coronavirus vaccines yesterday and has joined the list of countries aiming to return to old normal sooner than previously expected. The Indian drug regulator has approved the Oxford Covid-19 vaccine Covishield manufactured by the Indian Serum Institute (SII) and has independently developed Bharat Biotech’s Covaxin to limit emergency use. The SII vaccine, Covishield, will be the primary vaccine used while Covaxin is stored for emergency use. Covacin is still undergoing Phase 3 trials.

read more

Stock Market Live Today | Sensex, Nifty, BSE, NSE, Stock, Stock Market News Update January 4th

https://www.financialexpress.com/market/share-market-today-live-updates-sensex-nifty-rupee-vs-dollar-serum-institute-of-india-bharat-biotech-vaccine-approval-india-january-4-monday/2163539/ Stock Market Live Today | Sensex, Nifty, BSE, NSE, Stock, Stock Market News Update January 4th

Back to top button